TipRanks
Go Ultimate55% OFF

Krystal Biotech (KRYS) Balance Sheet

Krystal Biotech Balance Sheet

Krystal Biotech's total assets for Q2 2026 were $1.50B, an increase of 7.42% from the previous quarter. KRYS total liabilities were $141.52M for the fiscal quarter, a 17.70% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 1.33B$ 1.06B$ 818.36M$ 558.45M$ 626.29M
$ 114.23M$ 109.46M$ 39.71M$ 36.22M$ 32.72M
$ 1.22B$ 946.38M$ 778.64M$ 522.23M$ 593.58M

Currency in USD

Krystal Biotech Debt to Assets

0500M1B1.5B0 %4 %8 %12 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets